Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Thompson Peter A.
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-09-16
Purchase
2022-09-16
4:34 pm
Edgewise Therapeutics Inc.EWTXThompson Peter A.
Director
10% Owner
484,496$10.32$4,999,99914,301,551
(Indirect)
View
2022-05-18
Purchase
2022-05-20
4:32 pm
Edgewise Therapeutics Inc.EWTXThompson Peter A.
Director
10% Owner
138,000$7.21$994,98013,817,055
(Indirect)
View
2021-12-29
Sale
2021-12-30
8:55 pm
Janux Therapeutics Inc.JANXThompson Peter A.
Director
40,400$20.3$820,120231,098
(Indirect)
View
2021-12-21
Sale
2021-12-23
4:08 pm
Janux Therapeutics Inc.JANXThompson Peter A.
Director
119,400$19$2,268,600234,798
(Indirect)
View
2021-12-16
Sale
2021-12-17
5:16 pm
Janux Therapeutics Inc.JANXThompson Peter A.
Director
393,300$19.07$7,500,231245,898
(Indirect)
View
2021-09-20
Sale
2021-09-22
5:24 pm
Corvus Pharmaceuticals Inc.CRVSThompson Peter A.
Director
10% Owner
1,109,644$6.09$6,757,7326,943,654
(Indirect)
View
2021-09-17
Purchase
2021-09-21
6:38 pm
ALPINE IMMUNE SCIENCES INC.ALPNThompson Peter A.
Director
10% Owner
1,010,637$9.4$9,499,988425,531
(Indirect)
View
2021-06-15
Purchase
2021-06-16
6:20 pm
Janux Therapeutics Inc.JANXThompson Peter A.
Director
705,853$17$11,999,501282,398
(Indirect)
View
2021-03-30
Purchase
2021-03-31
7:11 pm
Edgewise Therapeutics Inc.EWTXThompson Peter A.
Director
10% Owner
359,375$16$5,750,00013,359,456
(Indirect)
View
2021-02-17
Purchase
2021-02-19
6:50 pm
Decibel Therapeutics Inc.DBTXThompson Peter A.
Director
10% Owner
1,666,666$18$29,999,988883,418
(Indirect)
View
2021-02-17
Purchase
2021-02-19
4:47 pm
Corvus Pharmaceuticals Inc.CRVSThompson Peter A.
Director
10% Owner
1,285,714$3.5$4,499,9998,053,298
(Indirect)
View
2020-12-28
Sale
2020-12-30
4:38 pm
ALPINE IMMUNE SCIENCES INC.ALPNThompson Peter A.
Director
10% Owner
600,000$14.25$8,550,0003,070,955
(Indirect)
View
2020-12-08
Purchase
2020-12-08
8:43 pm
Silverback Therapeutics Inc.SBTXThompson Peter A.
Director
10% Owner
1,190,477$21$25,000,0171,221,700
(Indirect)
View
2020-09-25
Purchase
2020-09-29
4:38 pm
PMV Pharmaceuticals Inc.PMVPThompson Peter A.
Director
10% Owner
950,000$18$17,100,000475,000
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-01-03
Option Award
2023-01-05
7:07 pm
N/A
2033-01-02
ALPINE IMMUNE SCIENCES INC.ALPNThompson Peter A.
Director
10,000$010,000
(Direct)
View
2022-08-11
Option Award
2022-08-15
6:47 pm
N/A
2032-08-11
Corvus Pharmaceuticals Inc.CRVSThompson Peter A.
Director
10% Owner
15,000$06,958,654
(Direct)
View
2022-06-24
Option Award
2022-06-28
7:17 pm
2023-06-08
2032-06-24
Edgewise Therapeutics Inc.EWTXThompson Peter A.
Director
10% Owner
42,087$042,087
(Direct)
View
2022-06-17
Option Award
2022-06-21
6:54 pm
N/A
2032-06-16
Decibel Therapeutics Inc.DBTXThompson Peter A.
Director
10% Owner
10,000$010,000
(Direct)
View
2022-06-15
Option Award
2022-06-17
5:35 pm
N/A
2032-06-15
Corvus Pharmaceuticals Inc.CRVSThompson Peter A.
Director
10% Owner
15,000$06,958,654
(Direct)
View
2022-06-14
Option Award
2022-06-16
4:35 pm
N/A
2032-06-13
Janux Therapeutics Inc.JANXThompson Peter A.
Director
12,500$012,500
(Direct)
View
2022-06-10
Option Award
2022-06-13
7:52 pm
N/A
2032-06-09
Silverback Therapeutics Inc.SBTXThompson Peter A.
Director
10% Owner
18,000$018,000
(Direct)
View
2022-01-03
Option Award
2022-01-04
5:19 pm
N/A
2032-01-02
ALPINE IMMUNE SCIENCES INC.ALPNThompson Peter A.
Director
10% Owner
10,000$010,000
(Direct)
View
2021-06-04
Option Award
2021-09-21
5:14 pm
N/A
2031-06-03
Silverback Therapeutics Inc.SBTXThompson Peter A.
Director
10% Owner
15,000$015,000
(Direct)
View
2021-09-09
Option Award
2021-09-13
4:53 pm
N/A
2031-09-09
Corvus Pharmaceuticals Inc.CRVSThompson Peter A.
Director
10% Owner
15,000$08,068,298
(Direct)
View
2021-06-15
Conversion
2021-06-16
6:20 pm
N/A
N/A
Janux Therapeutics Inc.JANXThompson Peter A.
Director
4,161,198$0282,398
(Indirect)
View
2021-06-15
Option Award
2021-06-16
4:15 pm
N/A
2031-06-15
Corvus Pharmaceuticals Inc.CRVSThompson Peter A.
Director
10% Owner
15,000$08,068,298
(Direct)
View
2021-06-10
Option Award
2021-06-14
5:43 pm
N/A
2031-06-09
Janux Therapeutics Inc.JANXThompson Peter A.
Director
10% Owner
30,000$030,000
(Direct)
View

Ownership
2021-06-10
7:22 pm
N/A
N/A
Janux Therapeutics Inc.JANXThompson Peter A.
Director
0$02,336,911
(Indirect)
View
2022-06-02
Option Award
2021-06-09
5:41 pm
N/A
2031-06-01
PMV Pharmaceuticals Inc.PMVPThompson Peter A.
Director
10% Owner
16,333$016,333
(Direct)
View
2021-03-30
Conversion
2021-03-31
7:11 pm
N/A
N/A
Edgewise Therapeutics Inc.EWTXThompson Peter A.
Director
10% Owner
25,732,796$013,359,456
(Indirect)
View

Ownership
2021-03-25
9:40 pm
N/A
N/A
Edgewise Therapeutics Inc.EWTXThompson Peter A.
Director
10% Owner
0$013,319,680
(Indirect)
View
2021-02-17
Conversion
2021-02-19
6:50 pm
N/A
N/A
Decibel Therapeutics Inc.DBTXThompson Peter A.
Director
10% Owner
20,654,719$0883,418
(Indirect)
View
2021-02-11
Option Award
2021-02-16
4:50 pm
N/A
2031-02-10
Decibel Therapeutics Inc.DBTXThompson Peter A.
Director
10% Owner
20,000$020,000
(Direct)
View

Ownership
2021-02-11
9:10 pm
N/A
N/A
Decibel Therapeutics Inc.DBTXThompson Peter A.
Director
10% Owner
0$03,278,526
(Indirect)
View
2021-01-22
Equity Swap
2021-01-26
5:05 pm
N/A
N/A
Prevail Therapeutics Inc.PRVLThompson Peter A.
Director
10% Owner
13,822,463$00
(Indirect)
View
2021-01-22
Disposition
2021-01-26
5:05 pm
N/A
N/A
Prevail Therapeutics Inc.PRVLThompson Peter A.
Director
10% Owner
17,000$00
(Direct)
View
2021-01-04
Option Award
2021-01-05
7:00 pm
N/A
2031-01-03
ALPINE IMMUNE SCIENCES INC.ALPNThompson Peter A.
Director
10% Owner
7,650$07,650
(Direct)
View
2020-12-08
Conversion
2020-12-08
8:43 pm
N/A
N/A
Silverback Therapeutics Inc.SBTXThompson Peter A.
Director
10% Owner
33,046,445$01,221,700
(Indirect)
View
2020-12-03
Option Award
2020-12-07
8:02 pm
N/A
2030-12-02
Silverback Therapeutics Inc.SBTXThompson Peter A.
Director
10% Owner
38,270$038,270
(Direct)
View

Ownership
2020-12-03
8:59 pm
N/A
N/A
Silverback Therapeutics Inc.SBTXThompson Peter A.
Director
10% Owner
0$07,550,411
(Indirect)
View
2020-09-29
Conversion
2020-09-29
4:38 pm
N/A
N/A
PMV Pharmaceuticals Inc.PMVPThompson Peter A.
Director
10% Owner
6,114,330$0475,000
(Indirect)
View

Ownership
2020-09-24
7:17 pm
N/A
N/A
PMV Pharmaceuticals Inc.PMVPThompson Peter A.
Director
10% Owner
0$06,114,330
(Indirect)
View
2020-06-17
Option Award
2020-06-19
6:40 pm
N/A
2030-06-17
Prevail Therapeutics Inc.PRVLThompson Peter A.
Director
10% Owner
17,000$017,000
(Direct)
View
2020-06-09
Option Award
2020-06-12
5:15 pm
N/A
2030-06-09
Corvus Pharmaceuticals Inc.CRVSThompson Peter A.
Director
10% Owner
15,000$06,782,584
(Direct)
View
2020-03-19
Option Award
2020-03-23
5:28 pm
N/A
2030-03-19
Corvus Pharmaceuticals Inc.CRVSThompson Peter A.
Director
10% Owner
15,000$06,782,584
(Direct)
View
2020-01-23
Disposition
2020-01-24
6:44 pm
N/A
2028-12-05
Synthorx Inc.THORThompson Peter A.
Director
10% Owner
30,000$570
(Direct)
View
2020-01-23
Equity Swap
2020-01-24
6:44 pm
N/A
N/A
Synthorx Inc.THORThompson Peter A.
Director
10% Owner
5,316,355$680
(Indirect)
View
2020-01-23
Disposition
2020-01-24
6:44 pm
N/A
2029-06-06
Synthorx Inc.THORThompson Peter A.
Director
10% Owner
15,335$55.60
(Direct)
View
Goto 0, 1, Next